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Clinical characterization of a family with a mutation in the Uromodulin, also known as Tamm-Horsfall (TH) gly-
uromodulin (Tamm-Horsfall glycoprotein) gene. coprotein [1], is the most abundant urinary protein in
Background. We have recently identified a mutation in the healthy individuals. Uromodulin has been postulated to
uromodulin gene in a large family affected with hyperuricemia,
be responsible for maintaining the integrity of the loopgout, and renal failure. The purpose of this investigation is
of Henle [2], preventing urinary tract infection [3], andto provide a comprehensive characterization of the clinical
binding cytokines such as interleukin-1 (IL-1) [4] andfindings of this syndrome in family members who had a muta-
tion in the uromodulin gene. tumor necrosis factor (TNF) [5]. However, despite being
Methods. An extended family suffering from hyperuricemia the most common urinary protein in healthy individuals,
and gout was identified by a local practitioner. After consent the exact function of uromodulin is unclear. In addition,
was obtained, patients provided a directed clinical history and there have been no previous reports of pathologic changesblood and urine specimens for chemical and genetic testing.
in this protein resulting in human disease. We have re-All family members were tested for the presence of uromodulin
cently reported mutations occurring in the uromodulingene mutations by direct DNA sequence analysis. The clinical
and biochemical characteristics of family members carrying the gene in four families [6]. These families developed gout,
affected mutation were then investigated. hyperuricemia, and renal failure. This investigation pro-
Results. Thirty-nine family members were found to have an vides an extensive characterization of the clinical changes
exon 5 uromodulin gene mutation (g.1966 1922 del), and 29 resulting from the uromodulin mutation in the largestunaffected family members were identified. The cardinal clini-
kindred, containing 39 affected family members.cal features in individuals with the uromodulin mutation in-
The constellation of findings seen in these families iscluded hyperuricemia, decreased fractional excretion of uric
acid, and chronic interstitial renal disease leading to end-stage consistent with two heritable illnesses transmitted as auto-
renal disease (ESRD) in the fifth through seventh decade. somal-dominant traits: familial juvenile hyperuricemic
Women did not always develop hyperuricemia or gout, but nephropathy (FJHN) and medullary cystic kidney disease
still developed progressive chronic renal failure.
type 2 (MCKD 2). FJHN, also known as familial juvenileConclusion. Mutation of the uromodulin gene resulted in
gouty nephropathy [Mendelian Inheritance in Man (MIM)hyperuricemia, reduced fractional excretion of uric acid, and
162000] [7], is an uncommon disorder characterized byrenal failure. Genetic testing will be required to definitively
identify individuals suffering from this condition. We are inter- reduced fractional excretion of uric acid and develop-
ested in studying other families that may suffer from this condi- ment of chronic renal failure. MCKD 2 (MIM 603860)
tion and would appreciate any such referrals. [8] is another uncommon genetic renal disease character-
ized by defects in urinary concentration, hyperuricemia,
and the development of ESRD. The genes responsible
Key words: uromodulin-associated kidney disease, juvenile hyperuri-
for these two conditions have been linked to similarcemic nephropathy, uric acid, genetic, medullary cystic kidney, uromo-
dulin, Tamm-Horsfall glycoprotein. genetic loci [9–12], and it has been postulated that these
diseases actually represent allelic mutations of the same
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due to small family sizes and lack of a certain diagnostic intron-exon junctions, were sequenced. Using oligonu-
cleotide primers, polymerase chain reaction (PCR) am-test. The family involved in this report represents one of
plification of the uromodulin gene was performed [6].the largest families ever reported suffering from FJHN,
Amplified DNA was purified with the QIAquick PCRMCKD 2, or related disorders. Ascertainment of the
Purification Kit (Quiagen) and was sequenced using themutation now allows for the first time a comprehensive
BigDye Terminator Cycle Sequencing Kit on an ABIgenotype-phenotype correlation permitting a more com-
3700 DNA Analyzer (Applied Biosystems, Foster City,plete clinical characterization of the range of clinical
CA, USA) by the Genomics and Proteomics Core Labo-findings associated with this syndrome and provides in-
ratories of the University of Pittsburgh. Sequence analy-creased information about the function of uromodulin.
sis was performed with Sequencher 4.1 software (Gene-
Codes, Ann Arbor, MI, USA).
METHODS
Clinical studies
RESULTS
A large family in western North Carolina was identi-
Over a 5-year period, genetic samples were obtainedfied by a local family practitioner (A.W.) and referred
on 10 controls (spouses of affected family members),for evaluation to Wake Forest University Medical Cen-
and 68 other family members.ter. The proband underwent diagnostic laboratory stud-
ies (see below), and family screenings were then held in Uromodulin sequence analysis
July 1996, October 1999, and March 2001. In addition,
Direct genomic sequence analysis of the uromodulinindividual visits were made to the homes of family mem-
gene identified a 27 base pair deletion in exon 5 in 39
bers. For each individual, a detailed clinical history, se-
family members. This deletion mutation (g.1966_1922
rum uric acid, and serum creatinine were obtained. For
del) results in the in-frame deletion of amino acids 177-
many participants, 24-hour urine collections were per- 185 (p. H177_R185 del). Thirty-nine individuals were
formed to determine the fractional excretion of uric acid found to have one mutated uromodulin allele and one
(mean fractional excretion of uric acid in healthy adult wild-type allele, consistent with autosomal-dominant
United Kingdom males is 8.1  3.2% and 12.8  2.9% transmission. Twenty-nine individuals were found to have
for females) [14]. Serum uric acid levels were also deter- two normal uromodulin genes. Segregation of the uro-
mined and hyperuricemia was based on the appropriate modulin gene mutation through this family was consis-
normal values for the patient’s age and gender [15, 16]. tent with autosomal-dominant transmission of the af-
The creatinine measurements were performed by the fected phenotype.
Jaffe, alkaline picrate, kinetic method [17]. The uric acid
measurements were performed on the ADVIA 1650 Index case
Chemistry System. The uric acid determination method The proband was identified in early 1995. He suffered
is based on the Fossati enzymatic reaction using uricase from enuresis until his early teenage years. He first suf-
with a Trinder-like end point [18]. Descriptive character- fered from gout at the age of 17 years. The patient was
istics were calculated for each patient. Estimates of creat- noncompliant with allopurinol, and over time, numerous
inine clearance, as determined by the Cockroft-Gault large tophi developed. At age 39 years, the serum creati-
formula [19], were made using the patient’s weight or nine was 2.8 mg/dL. A kidney biopsy specimen revealed
ideal body weight, whichever was less. Urine osmolality tubular atrophy and interstitial fibrosis. A computed
was determined by freezing point depression after an axial tomography scan of the abdomen revealed a 3.7 cm
overnight fast. simple cyst in the lower pole of the left kidney but no
Statistical analysis included multiple linear regression evidence of medullary cysts. At age 44 years, the patient
with estimates of creatinine clearance as the dependent was placed on peritoneal dialysis. The proband’s daugh-
variable, and age and gender as independent variables. ter was screened at age 20 years. At that time, the serum
Other models were also created using age, gender, use uric acid was 7.8 mg/dL, the fractional excretion of uric
of allopurinol, and serum uric acid levels as dependent acid 3.1%, and the creatinine clearance on a 24-hour
variables. The Wilcoxon rank-sum test was used to com- collection was 81 mL/min. Three years later, the serum
pare urine osmolality values. uric acid was 9.4 mg/dL with a fractional excretion of
uric acid of 4.1%, and the estimated creatinine clearance
Genetic studies was 85 mL/min. A computed axial tomography scan of
Peripheral venous blood samples were obtained by the abdomen revealed no medullary cysts in the kidney.
standard venipuncture and genomic DNA isolated using
Disorders in uric acid metabolismthe QIAmp blood kit (Qiagen, Valencia, CA, USA). To
determine if patients carried a mutation of the uromod- Hyperuricemia secondary to a reduced fractional ex-
cretion of uric acid was a cardinal manifestation of thisulin gene, all coding regions of exons 1-12, including
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Fig. 1. Serum uric acid values according to group. Fig. 2. Fractional excretion of uric acid according to renal function in
affected individuals.
Table 1. Patients with the uromodulin mutation who were
not hyperuricemic
four of five of these patients with follow-up measure-Estimated
creatinine Upper normal Fractional ments. The overlap of serum uric acid values between
Patient Age clearance Serum uric serum uric acid excretion of unaffected and affected female individuals was the resultnumber years mL/min acid mg/dL mg/dL uric acid %
of normal serum uric acid values in the five affected
1 17.2 91 4.8 6.26 5.1
women. In contrast, the serum uric acid values were all2 36.8 92 2.9 6.26 —
2 40.3 54 4.7 6.26 5.5 elevated in male patients, with the lowest value of 6.9
3 44.9 104 5.5 6.26 4.9 mg/dL. However, there was significant overlap between
3 49.6 56 5.7 6.26 —
unaffected individuals and affected individuals due to4 24.3 71 7.1 6.26 6.4
4 28.6 76 5.1 6.26 4.8 higher serum uric acid values in some of the unaffected
4 28.9 58 5.6 6.26 — individuals.5 62.7 24 6.0 6.26 —
Fractional excretion of uric acid
Fractional excretion varied greatly among both af-
fected and unaffected family members. In unaffecteddisorder. Figure 1 shows the distribution of serum uric
women, the fractional excretion of uric acid ranged fromacid levels in men and women older than age 16 years
3.1% to 10%. The fractional excretion of uric acid inwho were not on allopurinol. There were 109 determina-
affected females ranged from 1.7% to 6.7%. For affectedtions in 66 patients older than 16 years of age. The mean
males the fractional excretion ranged from 1.6% to 8.7%serum uric acid level for affected women was 7.49 1.71
and for unaffected males from 2.5% to 7.3%. The varia-mg/dL, compared to 4.24  1.09 mg/dL in control and
tion in fractional excretion of uric acid in affected indi-unaffected women (P  0.001). The mean serum uric
viduals was very much related to renal function andacid level for affected men was 9.43  1.78 mg/dL vs.
age. Figure 2 shows the fractional excretion of uric acid6.44  1.23 mg/dL in unaffected and control men (P 
according to estimated creatinine clearance in 25 collec-0.001). The youngest patient studied at age 6 years had
tions in women and 16 collections in men. For affectedan elevated serum uric acid level of 8.3 mg/dL (normal
women older than 18 years of age with estimated creati-for this age group 6.1 mg/dL) [15] and a reduced frac-
nine clearance greater than 80 mL/min, the fractional excre-tional excretion of uric acid of 5.7% (normal 15%)
tion ranged from 1.7% to 4.9%. For affected men older[20]. However, hyperuricemia was not a constant finding
than 18 years of age with estimated creatinine clearancein this condition, especially in women. There were five
greater than 80 mL/min from 1.6% to 4.1%. Reducedwomen with a serum uric acid measurement less than
fractional excretion of uric acid was a consistent finding inor equal to 6 mg/dL. Table 1 shows the characteristics
all affected patients with normal renal function. (In general,of these patients at different ages. These five patients
individuals with a creatinine clearance less than 80 mL/usually had depressed fractional excretions of uric acid
min will start developing an elevated fractional excretiondespite normal serum uric acid values. On repeat testing,
of uric acid [21].) Several unaffected and control patientsthe serum uric acid value appeared to stay relatively
also had fractional excretions less than 5%, a conditionconsistent, except for one patient who had one high
not uncommon in the general population [22].serum uric acid measurement followed by two normal
values. The estimated creatinine clearance declined in Eight of 28 women had a history of gout, with onset at
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Table 2. Urine osmolality obtained after an overnight fast in
affected participants
Estimated
Urine creatinine
Participant osmolality Age clearance
number mOsm/L years mL/mina
1 531 38 94
2 574 18 103
3 736 15 120
4 560 26 83
5 523 42 54
6 655 35 61
7 574 29 64
Fig. 3. Estimated creatinine clearance according to age in affected a Estimated creatinine clearance was determined 18 months prior to urine
individuals. osmolality determination
patients in whom multiple measurements were available.
In several patients, a rapid decline in renal function is
noted that reflects a small change in serum creatinine
resulting in a large change in creatinine clearance calcu-
lated by the Cockroft-Gault formula.
Declining renal function occurred over time even in
patients with normal serum uric acid levels and in those
who were taking allopurinol. Despite treatment with al-
lopurinol, four male patients had declines in estimated
creatinine clearance of greater than 3 mL/min/year on
determinations made 5 years apart.
Fig. 4. Estimated creatinine clearance according to age in affected
individuals who have multiple measurements of serum creatinine. Sym- Enuresis
bols are: () females and () males.
Ten of 39 affected patients suffered from enuresis ver-
sus three of 32 unaffected and controls (P  0.12 with
chi-squared test for statistical significance). Enuresis oc-
ages 17, 20, 32, 38, 46, 48, 58, and 62 years. Only women curred until the teenage years in several affected individ-
with gout were receiving allopurinol. Nine of 11 affected uals.
men suffered from gout; one of the unaffected men was
less than 18 years at the time of the study, and the other Urinary concentration
was 33 years old. Gout started between 18 and 25 years
Table 2 provides the results of maximal urinary con-in all men except one affected man at age 33 years.
centration after an overnight fast in seven affected indi-
viduals. These collections were performed approximatelyEstimated creatinine clearance
18 months after the estimated creatinine clearance deter-Renal insufficiency was the most consistent finding in
minations. The mean urine osmolality value was 593 the study. The estimated creatinine clearance values for
76 mOsm/kg in affected individuals versus 918  239affected patients according to age are presented in Figure
mOsm/kg in nine unaffected family members (P 0.01).3. Mild renal insufficiency tended to develop before age
If only the three affected individuals with an estimated20 years. In men, the decline in renal function appeared
creatinine clearance 90 mL/min were included, thesomewhat faster. Several patients have proceeded to di-
mean urine osmolality was 614  108 mOsm/kg versusalysis, including one male at age 44 years. Three women
918  239 mOsm/kg in the nine unaffected memberslived to age 60 years without starting dialysis; two of
(P  0.067).these began dialysis in their late sixties. One female
patient had a serum creatinine of 0.7 mg/dL and a normal
Hypertensionestimated creatinine clearance of 100 at age 44.9 years.
Ten of 13 patients with estimated creatinine clearanceHowever, at age 49.6 years, the estimated creatinine
less than 50 mL/min suffered from hypertension, sevenclearance had decreased to 56.0 mL/min and the serum
of 16 with estimated creatinine clearance between 50 andcreatinine increased to 1.3 mg/dL. Of note, this patient
80 mL/min, and zero of eight with estimated creatininehad normal serum uric acid levels on both occasions.
Figure 4 shows estimated creatinine clearance values for clearance values greater than 80 mL/min.
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Urinary tract infection urinary concentration if a function of uromodulin was
the preservation of the counter-current mechanism.Urinary tract infections did not occur in affected men.
Hyperuricemia occurred in 92% of the adult carriersIn 14 affected women, seven had not suffered from uri-
of the uromodulin mutation. Other studies have not beennary tract infections. One had suffered from more than
able to identify the penetrance of hyperuricemia in these10 urinary tract infections and had been referred to a
conditions due to the lack of a definite diagnostic test.urologist for a negative evaluation, and all other affected
Identification of the mutation allows a more accuratewomen had suffered from less than five infections. There
determination of the prevalence and significance of hyp-were only two instances of hospitalization for urinary
eruricemia. Further investigations will be required totract infection in the 14 women.
determine how a uromodulin mutation results in de-
creased urinary uric acid excretion. Difficulties in study-Pathology
ing this will include that renal insufficiency causes defectsKidney biopsy specimens were obtained on two men
in urinary concentration and hyperuricemia, and renaland one woman. These specimens revealed tubular atro-
insufficiency develops early in the course of this disease.phy and interstitial fibrosis with globally sclerotic glo-
While hyperuricemia was present in most family mem-meruli. No medullary cysts were identified, but the sam-
bers, it was not universally present. Hyperuricemia oc-ples were composed predominantly of cortical tissue.
curred more frequently and was more severe in maleComputed axial tomography scans were obtained on
individuals, with almost all affected males suffering fromtwo patients and did not reveal medullary cysts. Magnetic
gout in their twenties. Serum uric acid levels were higherresonance imaging was obtained on one patient at age
in men than in women. A number of female patients45 years and revealed medullary cysts. Several other
had normal serum uric acid levels, and many did notpatients underwent ultrasonographic examination. These
suffer from gout. While hyperuricemia was frequent, theexaminations characteristically do not reveal medullary
degree of hyperuricemia was not severe. As hyperuri-cysts, and they did not reveal cysts in these patients.
cemia is not uncommon in the general population, diag-
nosis of this condition based on elevated serum uric acid
DISCUSSION levels was not possible due to the overlap seen.
Renal insufficiency was more common than hyperuri-Uromodulin is the most common protein excreted in
cemia, occurring in all but one patient after the age ofthe urine in healthy individuals. This is the first clinical
20 years. Renal insufficiency occurred in patients withcharacterization of a family suffering from a mutation
normal serum uric acid levels as well as patients whoin the uromodulin gene. This mutation results in the
had been taking allopurinol for long periods of time.deletion of 9 amino acids in the uromodulin protein. This
This finding suggests that the renal insufficiency was notregion of the uromodulin protein is highly conserved
linked to the hyperuricemia. Previous pathologic studiesand this region is postulated to be very important in
of MCKD (of which this disease may be an example)determining protein structure [23]. Small in-frame dele-
have shown deposits of uromodulin in the renal intersti-tions are known to be responsible for a number of genetic
tium [26, 27]. It is possible that abnormal aggregation ofdiseases and are believed to be a major disease mecha-
uromodulin results in interstitial deposition. A mousenism in genetic diseases [24]. Once synthesized, uromo-
model that did not produce uromodulin has recentlydulin monomers aggregate and undergo glycosylation to
been found to have normal kidney structure and functionform a large glycoprotein. It is likely that this deletion
(abstract; Bates JM et al, J Am Soc Nephrol 13:55A,in affected family members results in abnormal aggrega-
2002), suggesting that abnormal aggregation of this pro-tion, affecting the structure and function of uromodulin.
tein may be integral in the development of renal failure.Hoyer, Sisson and Vernier [25] previously localized
Uromodulin also binds to various interleukins such asuromodulin by ultrastructural immunoperoxidase local-
TNF, and inability to bind to these molecules may leadization. Uromodulin was restricted to the thick ascending
to interstitial fibrosis. Kidney biopsies in family memberslimb and the early distal convoluted tubule and was dis-
were nonspecific. Most kidney biopsies were composedtributed between adjacent intercellular membranes, in
the infolding of intracellular membranes, and on the of renal cortex, and renal disease in these patients takes
place in the medulla of the kidney, with only secondaryluminal membranes. These authors postulated that uro-
modulin formed a gel that helped to restrict water move- changes in the cortex. Several women did not develop
ESRD into their sixties.ment along the thick ascending limb. In the current inves-
tigation, family members were found to have an increased It has been postulated that uromodulin may be impor-
tant in the prevention of urinary tract infection becauserate of enuresis and a decreased urinary concentrating
ability, although these differences were not statistically of its ability to bind to type I fimbriated Escherichia coli
[3]. However, the incidence and severity of urinary tractdifferent from controls. One would expect defects in
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